Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Olivia A. Walsh"'
Publikováno v:
Frontiers in Psychology, Vol 9 (2018)
Research has shown a negative relationship between weight bias internalization (WBI) and general measures of health-related quality of life (QOL), such as the Short Form–36. Less is known about the impact of WBI on weight-specific domains of QOL. T
Externí odkaz:
https://doaj.org/article/36925342e36a4e329894baa320f5cd0f
Publikováno v:
Membranes, Vol 13, Iss 11, p 864 (2023)
Antimicrobial peptides are key components of the immune system. These peptides affect the membrane in various ways; some form nano-sized pores, while others only produce minor defects. Since these peptides are increasingly important in developing ant
Externí odkaz:
https://doaj.org/article/d2555c2947744cf1be34fd20db61d42f
Autor:
Robert I. Berkowitz, Kathryn A. Gruber, Ariana M. Chao, Olivia A. Walsh, Jena Shaw Tronieri, Thomas A. Wadden, Naji Alamuddin
Publikováno v:
Obesity (Silver Spring)
Objective This exploratory analysis examined the effects of intensive behavioral therapy (IBT) for obesity ("IBT-alone"), IBT plus liraglutide 3.0 mg/d ("IBT-liraglutide"), and IBT plus liraglutide 3.0 mg/d plus 12 weeks of a portion-controlled diet
Autor:
Ariana M. Chao, Jena Shaw Tronieri, Robert I. Berkowitz, Kathryn A. Gruber, Thomas A. Wadden, Olivia A. Walsh, Naji Alamuddin
Publikováno v:
Int J Eat Disord
OBJECTIVE: This study examined what adults with binge-eating disorder (BED) and obesity perceived as the threshold for a large amount of food and how their evaluations compared to ratings by participants with obesity but without BED. METHOD: This was
Autor:
Kathryn A. Gruber, Ariana M. Chao, Naji Alamuddin, Zayna M. Bakizada, Thomas A. Wadden, Sharon M. Leonard, Olivia A. Walsh, Jena Shaw Tronieri, Robert I. Berkowitz
Publikováno v:
International journal of obesity (2005)
Background: Some weight loss medications, including liraglutide 3.0 mg, are thought to facilitate weight loss by improving appetite control. However, no studies have evaluated their long-term appetitive effects. Subjects/Methods: This study examined
Publikováno v:
J Nurs Scholarsh
Purpose To determine whether general healthcare providers and adult psychiatrists recognized binge eating disorder (BED) symptoms and features. The aims were to examine how they delineated the core criteria of BED-eating a large amount of food and se
Autor:
Robert I. Berkowitz, Thomas A. Wadden, Kelly C. Allison, Ariana M. Chao, Olivia A. Walsh, Jena Shaw Tronieri, Naji Alamuddin, Rebecca L. Pearl
Publikováno v:
Behav Med
Obesity is a complex disease caused by a wide array of behavioral, biological, and environmental factors. However, obesity is often attributed to oversimplified and stigmatizing causal factors such as laziness, lack of willpower, and failure to take
Autor:
Gozie Offiah, Olivia Claire Walsh, Anafal Alkharaing, Clare Sullivan, Clare Mullhall, Paul Tibbits, Arnold DK Hill, Claire Condron
Background Peer evaluation drives effective self-assessment, encourages autonomous learning and enhances both metacognitive skills and critical reasoning skills. 1 Students, by commenting on the work of others, gain a better understanding of the crit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06e28ee3dea3b444cc72165ffbbf4731
https://doi.org/10.21203/rs.2.22223/v1
https://doi.org/10.21203/rs.2.22223/v1
Autor:
Naji Alamuddin, Robert I. Berkowitz, Rebecca L. Pearl, Ariana M. Chao, Jena Shaw Tronieri, Olivia A. Walsh, Thomas A. Wadden
Publikováno v:
Annals of Behavioral Medicine. 53:782-787
Background The relationship between weight bias internalization (WBI) and long-term weight loss is largely unknown. Purpose To determine the effects of weight loss on WBI and assess whether WBI impairs long-term weight loss. Methods One hundred thirt
Autor:
Robert I. Berkowitz, Ariana M. Chao, Kathryn A. Gruber, Thomas A. Wadden, Jena Shaw Tronieri, Naji Alamuddin, Olivia A. Walsh
Publikováno v:
Clinical Obesity. 9
This study examined the effects of intensive behavioural therapy (IBT) for obesity (IBT-alone), IBT plus liraglutide 3.0 mg/day (IBT-liraglutide), and IBT-liraglutide combined with 12 weeks of a portion-controlled diet (Multicomponent) on changes in